GLOBAL X CHINA BIOTECH INNOVATION ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-0.38% | -18.02% |
Investment objective
The Global X China Biotech Innovation ETF (CHB) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 13.48 HKD | +5.81% | +6.81% | -54.46% | -.--% | ||
| 17.37 CNY | +2.72% | +3.52% | -26.74% | -.--% | ||
| 18.54 CNY | -2.63% | -2.57% | -16.22% | -.--% | ||
| 7.47 CNY | +0.81% | +0.27% | -22.83% | -.--% | ||
| 8.38 CNY | +1.70% | +1.82% | -17.76% | -.--% | ||
| 11.02 HKD | +2.42% | +5.56% | -44.51% | -.--% | ||
| 6.08 HKD | +0.50% | +9.35% | -19.15% | -.--% | ||
| 68.26 CNY | +7.67% | +2.31% | -9.14% | -.--% | ||
| 20.75 CNY | +7.01% | +4.06% | -23.57% | -.--% | ||
| 6.6 HKD | +1.23% | +14.38% | -9.09% | 8.82% | ||
More news
In partnership with
Description
| US37954Y2515 | |
|---|---|
| Total Expense Ratio | 0.65% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Solactive China Biotech Innovation GTR Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2020-09-21
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-01-30 )
| AuM (EUR) | 1 M€ |
|---|---|
| AuM 1M | 2 M€ |
| AuM 3 months | 2 M€ |
| AuM 6 months | 2 M€ |
| AuM 12 months | 3 M€ |
- Stock Market
- ETF
- CHB ETF
